Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-C Amigo

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Neurologia|October 29, 2021
Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the "no evidence of disease activity" parameterA Pato Pato, E Costa Arpín, A Rodríguez Regal, et al.
Revista De Neurologia|December 12, 2003
[Experience in the treatment of multiple sclerosis with interferon beta in Galicia]J Romero-López, M Seijo-Martínez, V Del Campo, et al.
Lupus|February 21, 2015
Lupus in Latin-American patients: lessons from the GLADEL cohortG J Pons-Estel, L J Catoggio, M H Cardiel, et al.
Revista De Neurologia|September 24, 2016
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia]A Pato-Pato, L Midaglia, E Costa-Arpin, et al.
Lupus|July 12, 2019
Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohortV R Pimentel-Quiroz, M F Ugarte-Gil, G B Harvey, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Neurologia|October 29, 2021
Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the "no evidence of disease activity" parameterA Pato Pato, E Costa Arpín, A Rodríguez Regal, et al.
Revista De Neurologia|December 12, 2003
[Experience in the treatment of multiple sclerosis with interferon beta in Galicia]J Romero-López, M Seijo-Martínez, V Del Campo, et al.
Lupus|February 21, 2015
Lupus in Latin-American patients: lessons from the GLADEL cohortG J Pons-Estel, L J Catoggio, M H Cardiel, et al.
Revista De Neurologia|September 24, 2016
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia]A Pato-Pato, L Midaglia, E Costa-Arpin, et al.
Lupus|July 12, 2019
Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohortV R Pimentel-Quiroz, M F Ugarte-Gil, G B Harvey, et al.
Pageof 5